29710-58-5

Downstream Products

• 162007-20-7 methyl N^α-[4-[2-(2,4-diamino-7H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-N^δ-(3,5-dimethoxycarbonylbenzenesulfonyl)-L-ornithinate 
• 886847-84-3 dimethyl 5-phenoxysulfonylisophthalate 
• 926291-89-6 5-hydrazosulfonylbenzene-1,3-carboxylic acid dimethyl ester 
• 1013296-47-3 C₁₇H₁₅NO₈S 
• 926291-99-8 4-butyloxy-3-methoxybenzophenone-(E)-3,5-dimethoxycarbonylphenylsulfohydrazone 
• 926291-98-7 4-octyloxy-3-methoxybenzophenone-(Z)-3,5-dimethoxycarbonylphenylsulfohydrazone 
• 926291-97-6 4-octyloxy-3-methoxybenzophenone-(E)-3,5-dimethoxycarbonylphenylsulfohydrazone 
• 926292-00-4 4-cetyloxybenzophenone-(E)-3,5-dimethoxycarbonylphenylsulfohydrazone 
• 926291-96-5 4-cetyloxy-3-methoxybenzophenone-(Z)-3,5-dimethoxycarbonylphenylsulfohydrazone 
• 926291-95-4 4-cetyloxy-3-methoxybenzophenone-(E)-3,5-dimethoxycarbonylphenylsulfohydrazone 
• 886847-86-5 phenyl 3,5-bis(chloromethyl)benzenesulfonate 
• 886847-85-4 phenyl 3,5-bis(hydroxymethyl)benzenesulfonate 
• 1221400-12-9 5-dimethylsulfamoyl-isophthalic acid dimethyl ester 
• 1221400-18-5 5-(piperidine-1-sulfonyl)-isophthalic acid dimethyl ester 

Relevant academic research and scientific papers

COLORED CURABLE COMPOSITION, COLOR FILTER AND METHOD OF PRODUCING THE SAME, AND DIPYRROMETHENE METAL COMPLEX COMPOUND AND TAUTOMER THEREOF

A colored curable composition is provided which has good developability, has excellent color purity, can be formed into a thin film, and has a high absorption coefficient. The colored curable composition includes at least one of specific dipyrromethene me

ASPARTYL PROTEASE INHIBITORS

A compound of formula (I): N-oxides, addition salts, quaternary amines metal complexes stereochemically isomeric forms and metabolites thereof, wherein A is CR1 or N; D is H, C1-C6alkyl, C2-C6alkenyl,

A method for producing an azo compound

A method for producing an azo derivative, comprising: (a) a step for allowing a diazotization agent, an acid or mixed acid having a Hammett acidity function Ho of -1.00 or less and an amino compound to undergo the reaction; and (b) a step for mixing a dia

Pharmacophore-based design of sphingosine 1-phosphate-3 receptor antagonists that include a 3,4-dialkoxybenzophenone scaffold

Sphingosine 1-phosphate (S1P) receptors are G-protein-coupled receptors. Among the five identified subtypes S1P1-5, the SIP3 receptor expressed on vascular endothelial cells has been shown to play an important role in cell proliferation, migration, and inflammation. A pharmacophore-based database search was used to identify a potent scaffold for an S1P3 receptor antagonist by common feature-based alignment and further validated using the Güner-Henry (GH) scoring method. Assumed excluded volumes were merged into this model to evaluate the steric effect with the S1P3 receptor. Three commercially available compounds were identified as S1P3 receptor antagonists, with IC50 values 3 receptor antagonist. Our results indicate that pharmacophore-based design of S1P3 receptor antagonists can be used to expand the possibility of structural modification through scaffold-hopping based on a database search.

Direct synthesis of poly(arylmethyl sulfone) monodendrons

Synthetic efforts toward poly(arylmethyl sulfone) dendrimers are described. A molecule designed to function as a protected AB2 monomer, phenyl 3,5-bis(chloromethyl)benzenesulfonate was synthesized in four steps from dimethyl 5-sulfoisophthalate